Genomix Pharmaceuticals Private Limited

Genomix Pharmaceuticals Private Limited - trading in Ranchi, Jharkhand, India. FY 2026 financials & compliance.
CIN U51909JH2011PTC014694 Incorporated 17 February 2011 ROC Ranchi HQ Ranchi, Jharkhand, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2024
₹3.19 Cr
▲ 19% YoY
Net profit · FY 2024
₹5.37 Lakh
Net margin 1.7%
EBITDA · FY 2024
₹12.35 Lakh
EBITDA margin 3.9%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹18 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹25 Lakh
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings

About Genomix Pharmaceuticals Private Limited

Data last updated:

Genomix Pharmaceuticals Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 17 February 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U51909JH2011PTC014694. Its GSTIN is 20AAECG2234M1ZX (Jharkhand).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹18 Lakh. It is led by directors including Rupa Kumari Gupta and Mira Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dinbandhu Lane Upper Bazar, Ranchi, Jharkhand, India – 834001.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.19 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹5.37 Lakh (net margin 1.7%) and EBITDA of ₹12.35 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 4% over five years.

As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹25 Lakh on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 3 cases are pending.

Genomix Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-20-0010342). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909JH2011PTC014694
Registration Number 014694
Incorporation Date 17 February 2011
ROC Ranchi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-JH-20-0010342

Recognitions & Rankings of Genomix Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-JH-20-0010342

Contact details

Genomix Pharmaceuticals Private Limited's registered office is in Ranchi, Jharkhand. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Dinbandhu Lane Upper Bazar, Ranchi, Jharkhand, India – 834001
  • Industry
    Trading, Wholesale, Other Wholesale

To see the full contact details of Genomix Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Genomix Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Genomix Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Genomix Pharmaceuticals Private Limited, buy the company report.

Financials of Genomix Pharmaceuticals Private Limited

FY 2025 filings available

Genomix Pharmaceuticals Private Limited reported revenue of ₹3.19 Cr (up 19% YoY) for FY 2024.

Revenue · FY 2024
₹3.19 Cr ▲ 19%
Net profit · FY 2024
₹5.37 Lakh margin 1.7%
EBITDA · FY 2024
₹12.35 Lakh margin 3.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 24%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 24%
5 years · compounded
▲ 10%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 19% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹12.35 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.37 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.9%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Genomix Pharmaceuticals Private Limited, buy the company report.

Board of directors of Genomix Pharmaceuticals Private Limited

Genomix Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rupa Kumari GuptaDirector17 Jun 20206 Years 4 MonthsCurrent
Mira GuptaDirector25 Jun 201313 Years 3 MonthsCurrent
Mrinal Kumar GuptaDirector17 Feb 201115 Years 8 MonthsCurrent

Peer comparison

Genomix Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pulin Pharmaceuticals Private Limited₹3.22 Cr (FY 2025)4.0%Jaipur, Rajasthan, India
Matmon Pharmaceuticals Private Limited₹3.22 Cr (FY 2025)35.0%Kolkata, West Bengal, India
Genomix Pharmaceuticals Private Limitedthis company₹3.19 Cr (FY 2024)₹5.37 Lakh1.7%19.0%Ranchi, Jharkhand, India
Shield & Care Pharmaceuticals Private Limited₹3.18 Cr (FY 2025)60.0%Ahmednagar, Maharashtra, India
Yuzderm Pharmaceuticals Private Limited₹3.17 Cr (FY 2025)61.0%Mumbai, Maharashtra, India

To see the full peer comparison of Genomix Pharmaceuticals Private Limited, buy the company report.

Auditor

Genomix Pharmaceuticals Private Limited is audited by OJHA & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
OJHA & ASSOCIATESFY 2017005634C

Shareholding

The shareholding of Genomix Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Genomix Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
₹25 Lakh
Breakdown by lending institutions
Others₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Sep 2020100375377Others₹50 LakhOpen
12 May 2016100029228Others₹25 LakhSatisfied

To see the full charge records of Genomix Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Genomix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Genomix Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
20AAECG2234M1ZXJharkhandActive01 Jul 2017

To see the full GST registrations and return filing status of Genomix Pharmaceuticals Private Limited, buy the company report.

Recent activity

Genomix Pharmaceuticals Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Rupa Kumari Gupta ceased to be Director on 12 Apr 2021.

AGM
Genomix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Genomix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi.
Ceased
Rupa Kumari Gupta ceased to be Director.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100375377 was registered on 11 Sep 2020.
Appointed
Rupa Kumari Gupta was appointed as Director.
Charges
A charge registered on 12 May 2016 via Charge ID 100029228 with Others was fully satisfied on 29 Aug 2019.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100029228 was registered on 12 May 2016.
Appointed
Mira Gupta was appointed as Director.
Ceased
Prabhat Kumar Sahu ceased to be Director.
Appointed
Mrinal Kumar Gupta was appointed as Director.
Incorporation
17 Feb 2011
Genomix Pharmaceuticals Private Limited was registered on 17 Feb 2011 with Roc Ranchi & aged 15 years 8 months as per MCA records.

Frequently asked questions

Genomix Pharmaceuticals is an active private limited company based in Ranchi, Jharkhand, India. The company works in wholesale, within the trading industry. It was incorporated on 17 February 2011 (15+ years old) and is registered under CIN U51909JH2011PTC014694.

Genomix Pharmaceuticals has 3 current directors:

The latest financial statements of Genomix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Genomix Pharmaceuticals is 20AAECG2234M1ZX, registered in Jharkhand.

The CIN (Corporate Identification Number) of Genomix Pharmaceuticals is U51909JH2011PTC014694. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Genomix Pharmaceuticals has 6 court cases on record: 5 filed by the company and 1 filed against it. 3 are pending. Most are in the district courts.

Genomix Pharmaceuticals was incorporated on 17 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ranchi.

The peers of Genomix Pharmaceuticals by revenue are Pulin Pharmaceuticals Private Limited, Matmon Pharmaceuticals Private Limited, Shield & Care Pharmaceuticals Private Limited, Yuzderm Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Rupa Kumari Gupta ceased to be Director on 12 Apr 2021. Rupa Kumari Gupta was appointed as Director on 17 Jun 2020. Mira Gupta was appointed as Director on 25 Jun 2013. Genomix Pharmaceuticals has 5 board changes on record in total.

Yes, Genomix Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-20-0010342).

The registered office of Genomix Pharmaceuticals is at Dinbandhu Lane Upper Bazar, Ranchi, Jharkhand, India – 834001.